NEAT1 modulation which regulates STAT3 appears very promising as a potential therapeutic approach, because STAT3 is a major BC marker with many upstream regulators and downstream targets which are known to promote BC malignancy and strong chemo-resistance [87]. Here, NEAT1 is linked to breast cancer.